Key Takeaways
- LRCX stock climbed approximately 1.42% to close at $310.10 on Friday amid positive tech sector momentum
- Fourth-quarter revenue reached $6.72 billion, surpassing analyst projections, while EPS of $1.82 exceeded the $1.68 forecast
- First-quarter 2027 revenue outlook of $7.70Bā$8.50B significantly outpaced the Wall Street consensus of $7.09B
- Institutional stakeholders control 84.61% of shares, with Eldred Rock Partners increasing holdings by 6.4%
- Wall Street analysts maintain a “Moderate Buy” rating with a consensus price target of $358.47
Lam Research (LRCX) advanced roughly 1.42% to settle at $310.10 on Friday, benefiting from widespread gains across the technology sector. The Nasdaq Composite rallied 1.12% while the S&P 500 increased 0.63%, with tech stocks leading the charge with a 1.20% gain.
Lam Research Corporation, LRCX
Friday’s upward movement reflected broad market momentum rather than company-specific catalysts. Eight out of 11 S&P 500 sectors finished in positive territory, with advancing issues outnumbering declining ones by approximately 2.7 to one.
The shares have also sustained positive momentum following the company’s fiscal fourth-quarter earnings announcement on July 29. That financial report provided investors with several encouraging data points.
Lam reported fourth-quarter revenue of $6.72 billion, exceeding analyst projections of $6.67 billion. Adjusted earnings per share reached $1.82, topping the consensus estimate of $1.68. Revenue expanded 30% compared to the same period last year.
The company achieved a gross margin of 51.7% and an operating margin of 37.4%. Lam Research concluded the quarter with $5.6 billion in cash, cash equivalents and restricted cash on its balance sheet.
Chief Executive Officer Tim Archer highlighted that the company achieved “record revenue, operating margin and earnings per share” during the June quarter, attributing the performance to AI-driven demand transforming the semiconductor equipment industry.
First-Quarter Outlook Crushes Wall Street Estimates
The forward guidance emerged as the headline grabber. Lam Research projected first-quarter 2027 revenue between $7.70 billion and $8.50 billion, substantially exceeding Wall Street’s $7.09 billion expectation. The EPS forecast range of $2.00 to $2.30 similarly surpassed the $1.83 consensus estimate.
Wall Street analysts currently anticipate the company will deliver full-year earnings per share of $9.24 for the ongoing fiscal year.
Institutional Investment Activity Continues
Eldred Rock Partners increased its LRCX holdings by 6.4% during the second quarter, acquiring an additional 4,289 shares to reach a total position of 71,251 shares. The investment is currently valued at approximately $30.9 million and represents 6.6% of the firm’s overall portfolio.
Multiple other institutional investors expanded their positions in recent quarters. Rokos Capital Management boosted its stake by 42% in the first quarter. Aware Super established a fresh position valued at around $60 million. Institutional investors and hedge funds collectively hold 84.61% of outstanding shares.
On the insider activity front, two board members divested shares through predetermined Rule 10b5-1 trading plans. Director Eric Brandt sold 54,500 shares at $350.80 in June, while Director Abhijit Talwalkar offloaded 18,282 shares at $335.00 in July. Combined insider sales over the previous 90 days totaled 80,441 shares worth approximately $27.6 million.
LRCX trades within a 52-week range spanning $94.11 to $438.50. The stock currently sits roughly 26% above its 200-day moving average while remaining approximately 8.5% below its 50-day moving average.
The Relative Strength Index registers at 48, indicating neutral momentum conditions. Critical support exists near $298.50, adjacent to the 100-day moving average.
Morgan Stanley preserved an Overweight rating while reducing its price target to $367. Wells Fargo and B. Riley both sustained bullish ratings with $350 targets. Mizuho assigns the stock an Outperform rating with a $400 price objective. The average analyst price target stands at $358.47.
LRCX concluded Friday’s session at $310.10, gaining 1.42%.


